Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A case control study-Reference-Cited by-同舟云学术

Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A case control study

Published:2006-01 Issue:1 Volume:5 Page:9-15
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Pressler Tacjana,Frederiksen Birgitte,Skov Marianne,Garred Peter,Koch Christian,Høiby Niels

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference55 articles.

1. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis;Farrell;Pediatr Pulmonol,2003

2. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation;Konstan;Am J Respir Crit Care Med,1994

3. Early pulmonary inflammation in infants with cystic fibrosis;Khan;Am J Respir Crit Care Med,1995

4. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis;Balough;Pediatr Pulmonol,1995

5. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis;Armstrong;BMJ,1995

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Close monitoring and early intervention: management principles for cystic fibrosis in Denmark;APMIS;2024-01-24

2. Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung;Journal of the Pediatric Infectious Diseases Society;2022-09-01

3. Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection;Biomedicines;2022-08-24

4. Material properties of interfacial films of mucoid and nonmucoid Pseudomonas aeruginosa isolates;Acta Biomaterialia;2020-12

5. Lung immunoglobulin A immunity dysregulation in cystic fibrosis;EBioMedicine;2020-10